NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Song, Shunxin ^a,b   Chen, Dianke ^a   Lu, Jiachun ^c   Liao, Jiawei ^a   Luo, Yanxin ^a,b   Yang, Zuli ^a,b   Fu, Xinhui ^a   Fan, Xinjuan ^a   Wei, Yisheng ^c   Yang, Lei ^c   Wang, Lei ^a,b   Wang, Jianping ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

3' UNTRANSLATED REGION; ADULT; AGE; ARTICLE; BODY MASS; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NFKAPPAB1 GENE; NFKAPPABIA GENE; RNA STABILITY; SEX; SMOKING; ASIAN; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; I-KAPPA B PROTEINS; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC;

EID: 79959692901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021726     Document Type: Article

References (54)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Cao KJ, Fan QY, Liu YL, Huang R, Yin CZ, et al. (2008) [Cancer incidence and mortality in Guangzhou City from 2000 to 2002]. Ai Zheng 27: 225-230.
3. Cheah PY, (2009) Recent advances in colorectal cancer genetics and diagnostics. Crit Rev Oncol Hematol 69: 45-55.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
5. Hoshiyama Y, Sekine T, Sasaba T, (1993) A case-control study of colorectal cancer and its relation to diet, cigarettes, and alcohol consumption in Saitama Prefecture, Japan. Tohoku J Exp Med 171: 153-165.
6. Tsong WH, Koh WP, Yuan JM, Wang R, Sun CL, et al. (2007) Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health Study. Br J Cancer 96: 821-827.
7. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180.
8. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, et al. (2007) The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 50: 839-855.
9. Eaden JA, Abrams KR, Mayberry JF, (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535.
10. Kerr JF, Wyllie AH, Currie AR, (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257.
11. Thompson CB, (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
12. Thompson HJ, Strange R, Schedin PJ, (1992) Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1: 597-602.
13. Baldwin AS Jr, (2001) Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107: 3-6.
14. Blank V, Kourilsky P, Israel A, (1992) NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 17: 135-140.
15. Hayden MS, West AP, Ghosh S, (2006) SnapShot: NF-kappaB signaling pathways. Cell 127: 1286-1287.
16. Gilmore TD, (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241-265.
17. Maldonado V, Melendez-Zajgla J, Ortega A, (1997) Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res 381: 67-75.
18. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, et al. (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812-1815.
19. Tanaka H, Hoshikawa Y, Oh-hara T, Koike S, Naito M, et al. (2009) PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation. Mol Cancer Res 7: 557-569.
20. Borset M, Hjorth-Hansen H, Johnsen AC, Seidel C, Waage A, et al. (1999) Apoptosis, proliferation and NF-kappaB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. Eur J Haematol 63: 345-353.
21. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, et al. (2003) Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 65: 37-45.
22. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, et al. (2001) Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 130: 363-369.
23. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643.
24. Shibata W, Takaishi S, Muthupalani S, Pritchard DM, Whary MT, et al. (2010) Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology 138: 1022-1034 e1021-1010.
25. Heron E, Deloukas P, van Loon AP, (1995) The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction. Genomics 30: 493-505.
26. Mathew S, Murty VV, Dalla-Favera R, Chaganti RS, (1993) Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. Oncogene 8: 191-193.
27. Le Beau MM, Ito C, Cogswell P, Espinosa R 3rd, Fernald AA, et al. (1992) Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics 14: 529-531.
28. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE, (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66: 1857-1862.
29. Ota N, Nakajima T, Shirai Y, Emi M, (1999) Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus. J Hum Genet 44: 129-130.
30. Glavac D, Ravnik-Glavac M, O'Brien SJ, Dean M, (1994) Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 93: 694-696.
31. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, et al. (2004) A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 19: 153-156.
32. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45.
33. Campbell KJ, Perkins ND, (2006) Regulation of NF-kappaB function. Biochem Soc Symp pp. 165-180.
34. Zhou B, Rao L, Li Y, Gao L, Wang Y, et al. (2009) A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 275: 72-76.
35. Kim LH, Shin HD, Park BL, Jung JH, Kim JY, et al. (2003) Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients. Hum Mutat 21: 652-653.
36. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, et al. (2007) Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol 42: 345-350.
37. Riemann K, Becker L, Struwe H, Nuckel H, Duhrsen U, et al. (2006) No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 16: 783-788.
38. Wei Y, Wang L, Lan P, Zhao H, Pan Z, et al. (2009) The association between -1304T>G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population. Int J Cancer 125: 1876-1883.
39. Zhou BF, (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83-96.
40. Sonenshein GE, (1997) Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol 8: 113-119.
41. Richmond A, (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2: 664-674.
42. Biswas DK, Cruz AP, Gansberger E, Pardee AB, (2000) Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A 97: 8542-8547.
43. Dolcet X, Llobet D, Pallares J, Matias-Guiu X, (2005) NF-kB in development and progression of human cancer. Virchows Arch 446: 475-482.
44. Amiri KI, Richmond A, (2005) Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev 24: 301-313.
45. Kurylowicz A, Miskiewicz P, Bar-Andziak E, Nauman J, Bednarczuk T, (2009) Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study. Thyroid Res 2: 10.
46. Miller MR, Zhang W, Sibbel SP, Langefeld CD, Bowden DW, et al. (2010) Variant in the 3′ region of the IkappaBalpha gene associated with insulin resistance in Hispanic Americans: The IRAS Family Study. Obesity (Silver Spring) 18: 555-562.
47. Bu H, Rosdahl I, Sun XF, Zhang H, (2007) Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol 133: 859-866.
48. Riemann K, Becker L, Struwe H, Rubben H, Eisenhardt A, et al. (2007) Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther 45: 423-430.
49. Conne B, Stutz A, Vassalli JD, (2000) The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 6: 637-641.
50. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
51. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35: 4535-4541.
52. Curran JE, Weinstein SR, Griffiths LR, (2002) Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 188: 103-107.
53. Sun XF, Zhang H, (2007) NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22: 1387-1398.
54. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U, (2010) Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 10: 484.